About Ride to End ALZ Leesburg
The Alzheimer's Association Ride to End ALZ is a cycling event to directly impact the pace and momentum behind the fight to end Alzheimer's. Inspired by science and driven by a determination to end this disease, participants in Ride to End ALZ raise funds and awareness to advance research toward the first survivor of Alzheimer's.
Fully supported, on and off the bike
Ride to End ALZ is a fully supported event for a range of riders, whether you're a novice cyclist, weekend warrior or avid enthusiast. Choose a virtual event or an in-person event that challenges you to go to distance to fight Alzheimer's.
You're not in this challenge alone — each rider will receive support from the Ride to End Alz staff and volunteer leadership committee. We are committed to providing fundraising and training support from registration to the day of Ride. Event day, our dedicated volunteers and crew will push you toward the finish line! You can do this!
Riders for the in-person events are required to make a registration donation to get started and agree to raise the fundraising minimum in order to participate. The challenge events and spoke series do not have a registration donation and fundraising is optional. Volunteers are not required to fundraise.
A ride to fuel research
As the world's largest nonprofit funder of Alzheimer's disease research, the Alzheimer's Association is setting the pace of the field with innovation and investment — and you're setting the pace with each pedal stroke.
Right now, there is no shortage of ideas in Alzheimer's research — only dollars. But you can help change that. The funds you raise through Ride to End ALZ directly impact the Association's ability to accelerate science toward methods of treatment and prevention for Alzheimer's and other dementias.
Join us as we cycle toward scientific progress in the fight against Alzheimer's. With each mile, you will fuel cutting-edge research with the potential to change the trajectory of the disease. Challenge yourself to go the distance for all those affected while raising funds and awareness to advance research toward the first survivor of Alzheimer's.
BACK TO TOP